Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Bluebird bio Inc

Bluebird bio Inc

BLUE · NASDAQ
BLUE · NASDAQ

Next Earnings: 24 Mar 2025

3.86
USD0.030.78%

Latest News

    SeekingAlpha

    bluebird bio stock slides for second day on buyout news

      CNBC

      Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker - CNBC

        SeekingAlpha

        bluebird bio announces take-private deal with Carlyle and SK Capital

          @Reuters
          Reuters

          U.S. FDA approves bluebird bio's gene therapy for a rare neurological disorder https://t.co/OTr4kvA3qD https://t.co/KitFoElcaz

            @Reuters
            Reuters

            U.S. FDA approves Bluebird bio's gene therapy for a rare neurological disorder https://t.co/eDvQRLmxIj https://t.co/hKzFYtXraI

              MarketWatch

              Dow Jones Newswires: Bluebird Bio stock rises 62%, FDA committee supports treatments

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              3.79USD
              3.88USD

              52 Week Range

              0.29USD
              10.28USD

              Market Cap

              39.06MUSD

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US09609G2093

              CUSIP

              09609G100

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              0.32

              Book Value

              -0.60

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -36

              Wall Street Target Price

              14.50

              EPS Estimate Current Year

              -27.67

              EPS Estimate Next Year

              -9.70

              EPS Estimate Current Quarter

              -0.35

              EPS Estimate Next Quarter

              -0.22

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              53,120,000

              Gross Profit TTM

              -25,663,000

              EBITDA

              -262,272,000

              Profit Margin

              0.00%

              Return On Assets TTM

              -36.91%

              Return On Equity TTM

              -270.20%

              Revenue Per Share TTM

              6.077

              Qtly Revenue Growth YOY

              -14.40%

              Diluted Eps TTM

              -36

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              0

              Price Sales TTM

              0.7262

              Price Book MRQ

              0.726

              Enterprise Value Revenue

              6

              Enterprise Value EBITDA

              -1

              Peers analysis

              • UCB SA ADR
                UCBJYUCB SA ADR

                98.50

                6.14%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                244.99

                2.61%
              • argenx NV ADR
                ARGXargenx NV ADR

                591.45

                1.76%
              • BioNTech SE
                BNTXBioNTech SE

                100.00

                1.71%
              • Be
                ONCBeiGene, Ltd.

                249.00

                1.34%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                494.74

                1.33%
              • CSL Ltd
                CSLLYCSL Ltd

                78.89

                0.66%
              • UCB SA
                UCBJFUCB SA

                184.83

                0.00%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                689.50

                -3.89%
              • CSL Limited
                CMXHFCSL Limited

                155.48

                -0.30%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Bluebird bio stock price today?

              What is Bluebird bio stock ticker?

              Is BLUE stock price going up?

              What is the analyst recommendation for BLUE?

              What is BLUE market cap?

              Does BLUE release financial reports?

              When is BLUE next earnings date?

              What were BLUE Earnings for the last quarter?

              What was BLUE Revenue for the last quarter?

              What was BLUE Net Income for the last quarter?

              Does BLUE pay dividends?

              How many employees does BLUE have?

              What is BLUE EBITDA?

              How to buy BLUE stocks?

              Should I invest in BLUE stock?